Global investment manager Oaktree is out with its third life sciences-dedicated special purpose acquisition company after ...

Kezar Life Sciences’ autoimmune drug candidate, zetomipzomib, has been put on hold by the FDA after the company said last ...

Upstream Bio, a mid-stage respiratory drug developer, and CAMP4 Therapeutics, a Phase 1 regulatory RNA startup, have unveiled ...

The activist investor Starboard Value has taken a stake in Pfizer, according to media reports, following the drugmaker's months of lackluster results as it came out of the pandemic and sought the next ...

Alnylam Pharmaceuticals has agreed to drop its 2023 patent lawsuit against Moderna in a Delaware court following a judge's ...

Andrew Miller has quickly made his first move after the technology he invented, KarXT, secured an FDA approval last week. The ...

This season’s uptake of RSV vaccines in the US has been slower than expected, according to Wall Street analysts tracking ...

Enliven Therapeutics released new Phase 1 data for its chronic myeloid leukemia program (CML) it hopes can eventually compete ...

The Center for Biomedical Advanced Research and Development Authority (BARDA) is giving $72 million to three drugmakers to ...

The European Medicines Agency is looking more closely at medicines used to treat hair loss and a condition caused by an ...

Gilead announced Wednesday that it will allow certain drug manufacturers to make and sell a generic version of its ...

Flagship Pioneering's roots in Singapore are growing less than a year after the biotech incubator first unveiled its ...